Closer Association of Liver Stiffness Than Liver Fat Content With Imaging‐Derived Neurovascular Coupling in a Metabolic Dysfunction‐Associated Steatotic Liver Disease Cohort
AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly linked to cognitive decline, yet the hepatic factors associated with imaging-derived neurovascular coupling (NVC) remain unclear. This study aimed to investigate whether liver stiffness or liver fat content was more closely associated with resting-state CBF-ReHo surrogate measures. MATERIALS AND METHODS: A total of 130 participants including 98 MASLD patients and 32 age- and education-matched healthy controls (HCs) underwent clinical assessment, neuropsychological testing, and multi-modal MRI. Liver stiffness and fat content were quantified using MR elastography (MRE) and MRI-proton density fat fraction (PDFF). Imaging-derived NVC was assessed using global cerebral blood flow (CBF)-regional homogeneity (ReHo) coupling and voxel-wise CBF/ReHo ratios, interpreted as resting-state surrogates rather than direct stimulus-evoked NVC. Multivariable regression and exploratory mediation analyses were employed. RESULTS: Compared to HCs and patients with lower liver stiffness (MASLD_low), those with higher liver stiffness (MASLD_high) showed reduced global CBF-ReHo coupling and altered CBF/ReHo ratios, primarily localized to the bilateral superior temporal pole/superior temporal gyrus (TPOsup). In multivariable regression, liver stiffness remained independently associated with TPOsup CBF/ReHo ratios (p < 0.001). Exploratory mediation analysis showed a statistically significant indirect association between hepatocellular injury markers and TPOsup CBF/ReHo ratios involving MRE-derived liver stiffness (95% CI: 0.0795-0.2790). CONCLUSIONS: Within this cohort and the observed PDFF range, MRE-derived liver stiffness was more closely associated with imaging-derived NVC surrogate measures than liver fat content in MASLD. These findings are hypothesis-generating and require validation in longitudinal studies.
Authors
- Futao Chen
- Qi Li (ORCID: https://orcid.org/0000-0001-8776-8730)
- Bing Zhang (ORCID: https://orcid.org/0000-0001-7592-1195)
- Weiping Li (ORCID: https://orcid.org/0000-0002-4839-2854)
- Jie Li (ORCID: https://orcid.org/0000-0003-0973-8645)
- Haitao Zhang (ORCID: https://orcid.org/0000-0002-1639-4089)
- Zhuoru Jiang
- Danni Ge
- J Lu
- Qian Chen
- Zhiwen Fan
- Jun Chen
- Zhengyang Zhu
- Xin Zhang
Institutions
- Mayo Clinic (US)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-07-22
- DOI
- https://doi.org/10.1111/dom.71125
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00